|

Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors

RECRUITINGN/ASponsored by Massachusetts General Hospital
Actively Recruiting
PhaseN/A
SponsorMassachusetts General Hospital
Started2026-07-01
Est. completion2030-07-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07014293

Summary

The goal of this clinical trial is to learn if a mind body resilience group program can help increase lymphoma survivors' ability to cope with and manage the challenges that come with the transition into early post treatment survivorship.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* English speaking adult (18 years or older at enrollment)
* At least 6-months post-lymphoma diagnosis and within 2 years of completing active, curative treatment for lymphoma (includes surgery, chemotherapy/immunotherapy/radiation therapy, or other)

Exclusion Criteria:

* Active Psychiatric or cognitive comorbidity as determined by site PI or treating clinician
* Unwilling or unable to participate using telehealth platform

Conditions2

CancerLymphoma

Locations1 site

Mass General Brigham
Boston, Massachusetts, 02114
Giselle Perez, PhD617-724-0765gperez@mgh.harvard.edu

Find trials near these locations

Cancer trials in BostonAll trials in Massachusetts

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.